Medication discrepancies at transitions in pediatrics

a review of the literature

Chi Huynh, Ian C.K. Wong, Stephen Tomlin, David Terry, Anthony Sinclair, Keith Wilson, Yogini Jani

Research output: Contribution to journalArticle

Abstract

Medication reconciliation is an important process in reducing medication errors in many countries. Canada, the USA, and UK have incorporated medication reconciliation as a priority area for national patient safety initiatives and goals. The UK national guidance excludes the pediatric population. The aim of this review was to explore the occurrence of medication discrepancies in the pediatric population. The primary objective was to identify studies reporting the rate and clinical significance of the discrepancies and the secondary objective was to ascertain whether any specific interventions have been used for medication reconciliation in pediatric settings. The following electronic bibliographic databases were used to identify studies: PubMed, OVID EMBASE (1980 to 2012 week 1), ISI Web of Science, ISI Biosis, Cumulative Index to Nursing and Allied Health Literature, and OVID International Pharmaceutical Abstracts (1970 to January 2012). Primary studies were identified that observed medication discrepancies in children under 18 years of age upon hospital admission, transfer and discharge, or had reported medication reconciliation interventions. Two independent reviewers screened titles and abstracts for relevant articles and extracted data using pre-defined data fields, including risk of bias assessment. Ten studies were identified with variances in reportage of stage and rate of discrepancies. Studies were heterogeneous in definitions, methods, and patient populations. Most studies related to admissions and reported consistently high rates of discrepancies ranging from 22 to 72.3 % of patients (sample size ranging from 23 to 272). Seven of the studies were low-quality observational studies and three studies were 'grey literature' non-peer reviewed conference abstracts. Studies involving small numbers of patients have shown that medication discrepancies occur at all transitions of care in children. Further research is required to investigate and demonstrate how implementing medication reconciliation can reduce discrepancies and potential patient harm.

Original languageEnglish
Pages (from-to)203-215
Number of pages13
JournalPediatric Drugs
Volume15
Issue number3
Early online date14 May 2013
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Medication Reconciliation
Pediatrics
Bibliographic Databases
Population
Patient Harm
Literature
Patient Transfer
Medication Errors
Patient Safety
PubMed
Sample Size
Canada
Observational Studies
Nursing
Health
Research
Pharmaceutical Preparations

Cite this

Huynh, Chi ; Wong, Ian C.K. ; Tomlin, Stephen ; Terry, David ; Sinclair, Anthony ; Wilson, Keith ; Jani, Yogini. / Medication discrepancies at transitions in pediatrics : a review of the literature. In: Pediatric Drugs. 2013 ; Vol. 15, No. 3. pp. 203-215.
@article{bd6e8f27a6544790bbb98b5b3557d5da,
title = "Medication discrepancies at transitions in pediatrics: a review of the literature",
abstract = "Medication reconciliation is an important process in reducing medication errors in many countries. Canada, the USA, and UK have incorporated medication reconciliation as a priority area for national patient safety initiatives and goals. The UK national guidance excludes the pediatric population. The aim of this review was to explore the occurrence of medication discrepancies in the pediatric population. The primary objective was to identify studies reporting the rate and clinical significance of the discrepancies and the secondary objective was to ascertain whether any specific interventions have been used for medication reconciliation in pediatric settings. The following electronic bibliographic databases were used to identify studies: PubMed, OVID EMBASE (1980 to 2012 week 1), ISI Web of Science, ISI Biosis, Cumulative Index to Nursing and Allied Health Literature, and OVID International Pharmaceutical Abstracts (1970 to January 2012). Primary studies were identified that observed medication discrepancies in children under 18 years of age upon hospital admission, transfer and discharge, or had reported medication reconciliation interventions. Two independent reviewers screened titles and abstracts for relevant articles and extracted data using pre-defined data fields, including risk of bias assessment. Ten studies were identified with variances in reportage of stage and rate of discrepancies. Studies were heterogeneous in definitions, methods, and patient populations. Most studies related to admissions and reported consistently high rates of discrepancies ranging from 22 to 72.3 {\%} of patients (sample size ranging from 23 to 272). Seven of the studies were low-quality observational studies and three studies were 'grey literature' non-peer reviewed conference abstracts. Studies involving small numbers of patients have shown that medication discrepancies occur at all transitions of care in children. Further research is required to investigate and demonstrate how implementing medication reconciliation can reduce discrepancies and potential patient harm.",
author = "Chi Huynh and Wong, {Ian C.K.} and Stephen Tomlin and David Terry and Anthony Sinclair and Keith Wilson and Yogini Jani",
year = "2013",
month = "6",
doi = "10.1007/s40272-013-0030-8",
language = "English",
volume = "15",
pages = "203--215",
journal = "Pediatric Drugs",
issn = "1174-5878",
publisher = "Adis International Ltd",
number = "3",

}

Medication discrepancies at transitions in pediatrics : a review of the literature. / Huynh, Chi; Wong, Ian C.K.; Tomlin, Stephen; Terry, David; Sinclair, Anthony; Wilson, Keith; Jani, Yogini.

In: Pediatric Drugs, Vol. 15, No. 3, 06.2013, p. 203-215.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Medication discrepancies at transitions in pediatrics

T2 - a review of the literature

AU - Huynh, Chi

AU - Wong, Ian C.K.

AU - Tomlin, Stephen

AU - Terry, David

AU - Sinclair, Anthony

AU - Wilson, Keith

AU - Jani, Yogini

PY - 2013/6

Y1 - 2013/6

N2 - Medication reconciliation is an important process in reducing medication errors in many countries. Canada, the USA, and UK have incorporated medication reconciliation as a priority area for national patient safety initiatives and goals. The UK national guidance excludes the pediatric population. The aim of this review was to explore the occurrence of medication discrepancies in the pediatric population. The primary objective was to identify studies reporting the rate and clinical significance of the discrepancies and the secondary objective was to ascertain whether any specific interventions have been used for medication reconciliation in pediatric settings. The following electronic bibliographic databases were used to identify studies: PubMed, OVID EMBASE (1980 to 2012 week 1), ISI Web of Science, ISI Biosis, Cumulative Index to Nursing and Allied Health Literature, and OVID International Pharmaceutical Abstracts (1970 to January 2012). Primary studies were identified that observed medication discrepancies in children under 18 years of age upon hospital admission, transfer and discharge, or had reported medication reconciliation interventions. Two independent reviewers screened titles and abstracts for relevant articles and extracted data using pre-defined data fields, including risk of bias assessment. Ten studies were identified with variances in reportage of stage and rate of discrepancies. Studies were heterogeneous in definitions, methods, and patient populations. Most studies related to admissions and reported consistently high rates of discrepancies ranging from 22 to 72.3 % of patients (sample size ranging from 23 to 272). Seven of the studies were low-quality observational studies and three studies were 'grey literature' non-peer reviewed conference abstracts. Studies involving small numbers of patients have shown that medication discrepancies occur at all transitions of care in children. Further research is required to investigate and demonstrate how implementing medication reconciliation can reduce discrepancies and potential patient harm.

AB - Medication reconciliation is an important process in reducing medication errors in many countries. Canada, the USA, and UK have incorporated medication reconciliation as a priority area for national patient safety initiatives and goals. The UK national guidance excludes the pediatric population. The aim of this review was to explore the occurrence of medication discrepancies in the pediatric population. The primary objective was to identify studies reporting the rate and clinical significance of the discrepancies and the secondary objective was to ascertain whether any specific interventions have been used for medication reconciliation in pediatric settings. The following electronic bibliographic databases were used to identify studies: PubMed, OVID EMBASE (1980 to 2012 week 1), ISI Web of Science, ISI Biosis, Cumulative Index to Nursing and Allied Health Literature, and OVID International Pharmaceutical Abstracts (1970 to January 2012). Primary studies were identified that observed medication discrepancies in children under 18 years of age upon hospital admission, transfer and discharge, or had reported medication reconciliation interventions. Two independent reviewers screened titles and abstracts for relevant articles and extracted data using pre-defined data fields, including risk of bias assessment. Ten studies were identified with variances in reportage of stage and rate of discrepancies. Studies were heterogeneous in definitions, methods, and patient populations. Most studies related to admissions and reported consistently high rates of discrepancies ranging from 22 to 72.3 % of patients (sample size ranging from 23 to 272). Seven of the studies were low-quality observational studies and three studies were 'grey literature' non-peer reviewed conference abstracts. Studies involving small numbers of patients have shown that medication discrepancies occur at all transitions of care in children. Further research is required to investigate and demonstrate how implementing medication reconciliation can reduce discrepancies and potential patient harm.

UR - http://www.scopus.com/inward/record.url?scp=84878759531&partnerID=8YFLogxK

UR - http://link.springer.com/article/10.1007%2Fs40272-013-0030-8

U2 - 10.1007/s40272-013-0030-8

DO - 10.1007/s40272-013-0030-8

M3 - Article

VL - 15

SP - 203

EP - 215

JO - Pediatric Drugs

JF - Pediatric Drugs

SN - 1174-5878

IS - 3

ER -